Adrenal and Gonadal Hormone Replacement in Anorexia Nervosa

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

April 30, 2004

Primary Completion Date

October 31, 2009

Study Completion Date

December 31, 2010

Conditions
Anorexia Nervosa
Interventions
DRUG

Hormone replacement therapy (estrogen/progestin)

Hormone replacement therapy (estrogen/progestin). 0.3 mg conjugated estrogens x 3 months, followed by 9 months of oral contraceptive (20 mg ethinyl estradiol + 0.1 mg levonorgestrel)

OTHER

Placebo (Sugar Pill)

Placebo (sugar pill)

DRUG

Dehydroepiandrosterone (DHEA)

50 mg tablet, 1 daily

Trial Locations (1)

02115

Children's Hospital Boston, Boston

All Listed Sponsors
collaborator

United States Department of Defense

FED

collaborator

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

lead

Boston Children's Hospital

OTHER

NCT00310791 - Adrenal and Gonadal Hormone Replacement in Anorexia Nervosa | Biotech Hunter | Biotech Hunter